Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on August 26, 2026

Silberstein & Miklos, P.C. (ASK4SAM) Expands Focus on Medical Malpractice and Hospital Negligence Claims in The Bronx
Spinal Rehab & Sports Medicine Kicks Off Back-to-School Sports Season Celebrating Nearly 30 Years of Elite-Level Care in Austin TX
Addressing Mental Health Disparities for Minorities
Cruel Summer: How Heat Can Turn Substance Use into a Medical Emergency
NeOnc’s Clinical Story Is Now the Main Event
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
Is Walking Your Dog Enough?
Nucleus and Legacy Partner to Help Families Decide If IVF is Right for Them
Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
Legato Emerges from Stealth with $12 Million in Funding to Pioneer a New Era of Hearing Devices with AI-Powered Hearing Glasses
9/11 Anniversary Nears and the Health Effects Are Still Emerging 25 Years Later
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board
20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
Celcuity Submits sNDA to FDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.